Work

Neuroleptic Malignant Syndrome on Chronic Trifluoperazine Therapy: A Diagnostic Dilemma

Year: 2025

Type: article

Abstract: Neuroleptic malignant syndrome (NMS) is a rare, life-threatening reaction to antipsychotic medication. This report describes the case of a 62-year-old male with chronic trifluoperazine use who presented with fever, rigidity, and altered mental status. Although sepsis or meningoencephalitis was initially suspected, an elevated creatine kinase and fulfillment of Levenson's criteria confirmed the diagnosis of NMS. The patient's condition improved following supportive care, administration of bromocriptine, and lorazepam. This case highlights the diagnostic challenges of NMS in patients on a stable antipsychotic regimen and underscores the importance of early recognition, particularly after excluding infectious etiologies.

Source: Clinical Case Reports

DOI: 10.1002/ccr3.71631

Authors: Sagun Baral, Sushmita Bhattarai, Khem Chandra Joshi

Institution: Rapti Academy of Health Sciences, Dang, Nepal

Language: English

Topic: Electroconvulsive Therapy Studies

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,820